Clinical Trials on Clear-Cell Metastatic Renal Cell Carcinoma in Korea, Democratic People's Republic of
Total 916 results
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZenecaActive, not recruitingNon Small Cell Lung Cancer MetastaticIreland, Singapore, Spain, Switzerland, Korea, Republic of, Netherlands
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
MedicalLogicKosin University Gospel HospitalUnknownCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Seoul National University HospitalRecruitingThyroid Cancer | Papillary Thyroid MicrocarcinomaKorea, Republic of
-
Hoffmann-La RocheActive, not recruitingMetastatic Melanoma | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Esophageal Squamous Cell Carcinoma (ESCC) | Small Cell Lung Cancer (SCLC)United States, Korea, Republic of, Denmark, France, Spain, New Zealand
-
Daiichi Sankyo Co., Ltd.ICON Clinical ResearchCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Daiichi Sankyo Co., Ltd.ICON Clinical ResearchCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Seoul National University HospitalActive, not recruitingThyroid Cancer | Papillary Thyroid MicrocarcinomaKorea, Republic of
-
Hoffmann-La RocheCompletedRenal Cell CarcinomaKorea, Republic of, United Kingdom, Denmark, France, Spain, Canada, United States, Germany, Italy
-
Seoul National University HospitalUnknownNeuroendocrine Carcinoma of Pancreas | Adenocarcinoma, PancreasKorea, Republic of
-
STCube, Inc.RecruitingExtensive Stage Small Cell Lung CancerUnited States, Korea, Republic of
-
National Cancer Center, KoreaUnknownCarcinoma, Non-Small-Cell Lung | Thoracic Surgery, Video-AssistedKorea, Republic of
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
Novartis PharmaceuticalsCompletedSquamous Cell Carcinoma of Head and Neck | Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma | HER2 + Breast Cancer | HER2 + Gastric CancerTaiwan, Spain, Canada, Korea, Republic of, United States
-
Asan Medical CenterCompletedPleural Effusion, Malignant | Non-small Cell CarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedWHYX Lesion | Extremely Well Differentiated Intestinal-type AdenocarcinomaKorea, Republic of
-
TakedaRecruitingCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma KinaseKorea, Republic of
-
Samsung Medical CenterCytoGen, Inc.; UNIST (Ulsan National Institute of Science and Technology)Active, not recruitingNSCLC Stage IV | NSCLC Stage IIIBKorea, Republic of
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Ovarian Carcinoma | Ovarian Clear Cell AdenocarcinomaUnited States, Korea, Republic of
-
Samsung Medical CenterCompleted
-
Millennium Pharmaceuticals, Inc.TerminatedSmall Cell Lung Cancer | Ovarian Cancer | Advanced Solid TumorsJapan, Korea, Republic of
-
IpsenCompletedRenal Cell Carcinoma | Hepatocellular Carcinoma | Differentiated Thyroid CarcinomaKorea, Republic of
-
AstraZenecaQuintiles, Inc.CompletedNon Small Cell Lung CancerKorea, Republic of, Spain, France
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
National Cancer Center, KoreaUnknownLimited Disease Small Cell Lung CancerKorea, Republic of
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Chonnam National University HospitalAstraZenecaCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
GlaxoSmithKlineCompletedPathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)Singapore, Korea, Republic of
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerChina, Korea, Republic of, Taiwan
-
Bridge Biotherapeutics, Inc.RecruitingEGFR Mutant Advanced Non-Small Cell Lung CancerKorea, Republic of, United States
-
SillaJen, Inc.Regeneron PharmaceuticalsActive, not recruitingRenal Cell CarcinomaUnited States, Australia, Korea, Republic of
-
PfizerCompletedHepatocellular Carcinoma | Advanced Breast Cancer | Non-Small Cell Lung Cancer | Metastatic Breast Cancer | Metastatic Renal Cell Cancer | Thyroid Cancer | Pancreatic Neuroendocrine Tumor | Gastrointestinal Stromal Tumor | Advanced Gastric Cancer | Metastatic Castration Resistant Prostate Cancer | Advanced... and other conditionsUnited States, Spain, Korea, Republic of, France, Australia, United Kingdom, Canada, Brazil, Argentina, Taiwan, Belgium, Colombia, Germany, Hong Kong, Mexico, Philippines, Singapore
-
National Cancer Center, JapanRecruitingCervical Cancer | Nasopharyngeal Carcinoma | Ovarian Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Ovarian Clear Cell CarcinomaJapan, Korea, Republic of, Malaysia, Thailand, Philippines, Singapore, Taiwan, Vietnam
-
Clinical Research Center for Solid Tumor, KoreaCompletedSmall Cell Lung CancerKorea, Republic of
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Korea University Guro HospitalChong Kun Dang Pharmaceutical Corp.Active, not recruitingEGFR Positive Non-small Cell Lung CancerKorea, Republic of
-
Incyte CorporationTerminatedMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Non Small Cell Lung Cancer | Urothelial CancerKorea, Republic of, Bulgaria, Hungary, Taiwan, Ukraine
-
National Cancer Center, KoreaPfizer; Roche Pharma AGUnknownNSCLC | Lung CancerKorea, Republic of
-
Konkuk University Medical CenterYuhan CorporationRecruitingNon Small Cell Lung CancerKorea, Republic of
-
Boehringer IngelheimApproved for marketingCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Medicenna Therapeutics, Inc.Merck Sharp & Dohme LLCRecruitingClear Cell Renal Cell Carcinoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Primary Peritoneal Cancer | Endometrial Carcinoma and other conditionsUnited States, Australia, Korea, Republic of, Canada
-
AstraZenecaParexelTerminatedNon Small Cell Lung CancerUnited States, Korea, Republic of
-
SanofiActive, not recruitingNon-small Cell Lung Cancer MetastaticKorea, Republic of, United States, Bulgaria, Czechia, Portugal, Spain
-
Chonnam National University HospitalSanofiTerminatedCarcinoma, Non Small Cell LungKorea, Republic of
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
Novartis PharmaceuticalsCompletedEsophageal Squamous Cell CarcinomaTaiwan, Spain, Canada, Singapore, Hong Kong, Korea, Republic of, Belgium, United Kingdom, United States
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell Lung | Small Cell Lung Carcinoma | Carcinoma, Squamous Cell of Head and NeckUnited States, Taiwan, Korea, Republic of, Japan, Spain
-
Ono Pharmaceutical Co. LtdCompletedAdvanced Non-small Cell Lung CancerKorea, Republic of